These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 932943

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Some pharmacologic and toxicologic effects of di-2-ethylhexyl phthalate (DEHP) and other plasticizers.
    Rubin RJ, Jaeger RJ.
    Environ Health Perspect; 1973 Jan; 3():53-9. PubMed ID: 4704572
    [No Abstract] [Full Text] [Related]

  • 4. The absorption, metabolism and tissue distribution of di(2-ethylhexyl)phthalate in rats.
    Daniel JW, Bratt H.
    Toxicology; 1974 Mar; 2(1):51-65. PubMed ID: 4823738
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE, Anders MW, Mannering GJ.
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract] [Full Text] [Related]

  • 7. Hexobarbital action in rats with flavonoid-deficiency.
    Endell W, Seidel G.
    Experientia; 1976 Sep 15; 32(9):1189-90. PubMed ID: 971760
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of subchronic treatment with (-) 8 -trans-tetrahydrocannabinol ( 8 -THC) on food intake, body temperature, hexobarbital sleeping time and hexobarbital elimination in rats.
    Rating D, Broermann I, Honecker H, Kluwe S, Coper H.
    Psychopharmacologia; 1972 Sep 15; 27(4):349-57. PubMed ID: 4648618
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.
    Stavchansky SA, Lubawy WC, Kostenbauder HB.
    Life Sci; 1974 Apr 16; 14(8):1535-9. PubMed ID: 4829543
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
    Weiner M, Buterbaugh GG, Blake DA.
    Res Commun Chem Pathol Pharmacol; 1972 Mar 16; 3(2):249-63. PubMed ID: 4372659
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of 1,1,1-trichloroethane administered by different routes and in different solvents on barbiturate hypnosis and metabolism in mice.
    Shan HC, Lal H.
    J Toxicol Environ Health; 1976 May 16; 1(5):807-16. PubMed ID: 1271486
    [Abstract] [Full Text] [Related]

  • 20. Effect of subacute intoxication with some heavy metals on hexobarbital sleep and metabolism.
    Stoytchev T, Krotev L.
    Acta Physiol Pharmacol Bulg; 1978 May 16; 4(3):29-35. PubMed ID: 751449
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.